Open Label Phase II Trail to Evaluate the Safety and Efficacy of Aztreonam 75mg Powder and Solvent for Nebulizer Solution/Aztreonam for Inhalation solution (AZLI) in Pediatric Patients with Cystic Fibrosis (CF) and New Onset Lower Respiratory Tract Cultu
Study on Investigational Treatment for Lung Infections in CF Patients
Brief description of study.
The purpose of this research study is to see if an experimental drug called Aztreonam for Inhalation Solution is safe and effective at treating, and completely getting rid of PA lung infections in patients with CF.
Detailed description of study
The purpose of this research study is to see if an experimental drug called Aztreonam for Inhalation Solution is safe and effective at treating, and completely getting rid of PA lung infections in patients with CF.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Cystic Fibrosis
-
Age: 100 years or below
-
Gender: All
This study investigates the safety and effectiveness of an investigational medication for treating lung infections caused by PA (Pseudomonas aeruginosa) in patients with cystic fibrosis (CF). Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory and digestive problems.
Participants in the study will receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine. The study will compare the outcomes of these two groups to determine the medication's effectiveness.
- Who can participate: Eligible participants are individuals diagnosed with cystic fibrosis, within a specified age range.
- Study details: Participants will be assigned to receive either the investigational medication or a placebo.
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
Please choose between Voice or SMS based delivery of verification code
or